Polish Pharmaceuticals & Biotech Insider-Bought Value Plays

Selvita

Market Cap: zł550.7m

Provides drug discovery, drug development, and contract testing services in Poland.

Genomed Spólka Akcyjna

Market Cap: zł35.9m

Provides DNA sequencing and analysis and diagnostics services for congenital diseases in Poland.

Ryvu Therapeutics

Market Cap: zł346.3m

A clinical-stage drug discovery and development company, engages in developing of small molecule therapies for treatment in oncology in Poland, European Union, and internationally.